PMC:7652766 / 84184-84717
Annnotations
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T122 | 66-72 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
T123 | 482-497 | Phenotype | denotes | cytokine storms | http://purl.obolibrary.org/obo/HP_0033041 |
T124 | 507-513 | Phenotype | denotes | sepsis | http://purl.obolibrary.org/obo/HP_0100806 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T411 | 0-222 | Sentence | denotes | The clinical use of IL-7 has been implemented in the treatment of cancer patients and infectious diseases, mainly with the objective of improving the immune response by stimulating the generation of lymphocytes (298, 299). |
T412 | 223-533 | Sentence | denotes | In addition, IL-7 administration has been reported to increase CD4 + and CD8 + T lymphocyte counts without inducing the production of pro-inflammatory mediators, making it a promising method of recovering immune function in patients with disorders related to cytokine storms, such as sepsis and COVID-19 (300). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3051 | 20-24 | Gene | denotes | IL-7 | Gene:3574 |
3052 | 236-240 | Gene | denotes | IL-7 | Gene:3574 |
3053 | 286-289 | Gene | denotes | CD4 | Gene:920 |
3054 | 296-299 | Gene | denotes | CD8 | Gene:925 |
3055 | 479-481 | Gene | denotes | to | Gene:6999 |
3056 | 274-276 | Gene | denotes | to | Gene:6999 |
3057 | 73-81 | Species | denotes | patients | Tax:9606 |
3058 | 447-455 | Species | denotes | patients | Tax:9606 |
3059 | 395-396 | Gene | denotes | a | Gene:351 |
3060 | 66-72 | Disease | denotes | cancer | MESH:D009369 |
3061 | 86-105 | Disease | denotes | infectious diseases | MESH:D003141 |
3062 | 507-513 | Disease | denotes | sepsis | MESH:D018805 |
3063 | 518-526 | Disease | denotes | COVID-19 | MESH:C000657245 |